583.80

0.27% -1.205

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $583.80, with a volume of 71,287. It is down -0.27% in the last 24 hours and up +6.79% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$585.01

Open:

$590.45

24h Volume:

71,287

Relative Volume:

0.19

Market Cap:

$16.30B

Revenue:

$2.68B

Net Income/Loss:

$460.40M

P/E Ratio:

36.73

EPS:

15.8963

Net Cash Flow:

$711.00M

1W Performance:

+1.09%

1M Performance:

+6.79%

6M Performance:

+7.63%

1Y Performance:

+36.06%

1-Day Range:

$582.08

$594.99

1-Week Range:

$563.45

$594.99

52-Week Range:

$373.00

$677.90

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1083)

Industry

Diagnostics & Research (49)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

6,300

Twitter

@WorkatMedpace

Next Earnings Date

2026-07-22

Latest SEC Filings

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, IDXX, NTRA, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEDP Medpace Holdings Inc	584.01	16.45B	2.68B	460.40M	711.00M	15.90
TMO Thermo Fisher Scientific Inc	587.13	207.93B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	203.72	138.14B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	587.76	43.87B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	317.63	36.95B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	145.09	38.94B	7.23B	1.41B	1.09B	4.979

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-26	Upgrade	Barclays	Underweight → Equal Weight
Mar-03-26	Initiated	RBC Capital Mkts	Outperform
Feb-18-26	Upgrade	TD Cowen	Sell → Hold
Feb-13-26	Upgrade	Jefferies	Hold → Buy
Feb-10-26	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Jul-29-25	Downgrade	UBS	Neutral → Sell
Jul-23-25	Downgrade	TD Cowen	Hold → Sell
Jun-24-25	Initiated	Barclays	Equal Weight
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold
Mar-24-25	Initiated	Leerink Partners	Market Perform
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

Jul 28, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jul 28, 2026

Medpace (NASDAQ: MEDP) holder to sell 4,000 shares after earlier 11,000-sale - Stock Titan

Jul 28, 2026

Medpace Holdings, Inc. Stock 12‑Month Price Target Raised to $601.09, Implies 2% Upside - TradingView

Jul 28, 2026

Form 144 Medpace Holdings For: 28 July By Investing.com - Investing.com India

Jul 28, 2026

Jul 27, 2026

Medpace Holdings, Inc. SEC Filing (Jul 27, 2026) - Stock Titan

Jul 27, 2026

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP) - Yahoo Finance UK

Jul 27, 2026

Medpace Holdings revenue up 17.2% to USD 707.3M in Q2 2026 - Medical Buyer

Jul 27, 2026